Literature DB >> 11819079

Vertebral anomalies in children with Alagille syndrome: an analysis of 50 consecutive patients.

Evelyn Sanderson1, Vanessa Newman, Susan F Haigh, Alastair Baker, Paul S Sidhu.   

Abstract

BACKGROUND: Vertebral anomalies may help differentiate Alagille syndrome from other causes of chronic cholestasis. We suspect significant under-reporting of vertebral anomalies in children with Alagille syndrome.
OBJECTIVE: To compare the vertebral anomalies in Alagille syndrome with those in patients with chronic cholestasis due to other causes. The accuracy of original radiographic reporting was evaluated.
MATERIALS AND METHODS: Spinal radiographs of 50 patients with Alagille syndrome and 31 non-Alagille syndrome cholestatic patients were evaluated retrospectively by four trained radiologists. The number, site and type of vertebral anomaly were noted. The consensus evaluation was then compared to the original report.
RESULTS: Vertebral anomalies were found in 66% of patients with Alagille syndrome and 9.7% of cholestatic control subjects ( P<0.0005). In the patients with Alagille syndrome, incomplete fusion of the anterior arch, most frequently at the D6-9 level, accounted for 123 of 126 anomalies. Multiple vertebral anomalies occurred in 48% of patients with Alagille syndrome (mean 2.5 anomalies). Vertebral anomalies were misreported in 54% of cases of Alagille syndrome.
CONCLUSIONS: Vertebral anomalies are significantly more common in Alagille syndrome than in chronic cholestasis of other causes and are frequently overlooked. Reporting should be undertaken by a radiologist familiar with the appearance and location of these vertebral anomalies.

Entities:  

Mesh:

Year:  2001        PMID: 11819079     DOI: 10.1007/s00247-001-0599-x

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  11 in total

Review 1.  Alagille syndrome: pathogenesis, diagnosis and management.

Authors:  Peter D Turnpenny; Sian Ellard
Journal:  Eur J Hum Genet       Date:  2011-09-21       Impact factor: 4.246

2.  Mib-Jag1-Notch signalling regulates patterning and structural roles of the notochord by controlling cell-fate decisions.

Authors:  Mai Yamamoto; Ryoko Morita; Takamasa Mizoguchi; Hiromi Matsuo; Miho Isoda; Tohru Ishitani; Ajay B Chitnis; Kunihiro Matsumoto; J Gage Crump; Katsuto Hozumi; Shigenobu Yonemura; Koichi Kawakami; Motoyuki Itoh
Journal:  Development       Date:  2010-06-23       Impact factor: 6.868

Review 3.  Notch signaling and bone remodeling.

Authors:  Jenna Regan; Fanxin Long
Journal:  Curr Osteoporos Rep       Date:  2013-06       Impact factor: 5.096

Review 4.  Alagille syndrome: case report with bilateral radio-ulnar synostosis and a literature review.

Authors:  R S Ryan; S O Myckatyn; G D Reid; P Munk
Journal:  Skeletal Radiol       Date:  2003-06-11       Impact factor: 2.199

5.  Oral manifestations of Alagille syndrome.

Authors:  Anne-Laure Bonnet; Victor Greset; Tiphaine Davit-Beal
Journal:  BMJ Case Rep       Date:  2020-05-31

6.  Williams syndrome presenting with findings consistent with Alagille syndrome.

Authors:  Pankaj Sakhuja; Hilary Whyte; Binita Kamath; Nicole Martin; David Chitayat
Journal:  Clin Case Rep       Date:  2014-11-07

Review 7.  Alagille syndrome: clinical perspectives.

Authors:  Maha Saleh; Binita M Kamath; David Chitayat
Journal:  Appl Clin Genet       Date:  2016-06-30

8.  Persistent cholestasis resulting from duodenal papillary carcinoma in an adolescent male: A case report.

Authors:  Haiyan Fu; Yingchao Li; Gelan Bai; Runkai Yin; Chunlan Yin; Weina Shi; Lili Zhang; Rongpin Li; Ruiqin Zhao
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

Review 9.  Alagille Syndrome: Diagnostic Challenges and Advances in Management.

Authors:  Mohammed D Ayoub; Binita M Kamath
Journal:  Diagnostics (Basel)       Date:  2020-11-06

Review 10.  Neuroradiological findings in Alagille syndrome.

Authors:  Alessandra D'Amico; Teresa Perillo; Renato Cuocolo; Lorenzo Ugga; Fabiola Di Dato; Ferdinando Caranci; Raffaele Iorio
Journal:  Br J Radiol       Date:  2021-10-05       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.